David Zientek in Austin, Texas

Additional Medical Specialties Include:
CARDIOVASCULAR DISEASE (CARDIOLOGY)

Medical School: Johns Hopkins University School Of Medicine
Graduation Year: 1985
The Primary Medical Specialty for David Zientek is listed as: Interventional Cardiology
Approximate Years of Experience: 40
PAC (PECOS ID)#: 7517051865
NPI #: 1629053061
NPI Created On: 12/08/2005
NPI Last Updated Listed as: 10/28/2016
Primary Taxonomy Code: 207RC0000X
License Number:
J1821
Listed Gender: Male

---

Forms of insurance accepted by include, but are not limited to:

• FirstCare Health Plans
• Humana
• Molina Marketplace
• Celtic Insurance Company
• Oscar Insurance Company
• Blue Cross Blue Shield
• Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English, Spanish.

---

Services and Procedures include:

1. Nuclear medicine study of vessels of heart using drugs or exercise multiple studies
2. Nuclear medicine study of vessels of heart using drugs or exercise multiple studies
3. Exercise or drug-induced heart and blood vessel stress test with ekg monitoring, physician supervision, interpretation, and report
4. Exercise or drug-induced heart and blood vessel stress test with ekg monitoring and physician supervision
5. Exercise or drug-induced heart and blood vessel stress test with ekg monitoring, physician interpretation and report
6. Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function
7. Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function
8. Established patient office or other outpatient visit, typically 15 minutes
9. Established patient office or other outpatient, visit typically 25 minutes
10. Initial hospital inpatient care, typically 50 minutes per day
11. Initial hospital inpatient care, typically 70 minutes per day
12. Subsequent hospital inpatient care, typically 25 minutes per day
13. Subsequent hospital inpatient care, typically 35 minutes per day
14. Technetium tc-99m sestamibi, diagnostic, per study dose
15. Injection, regadenoson, 0.1 mg

They took part in Medicare's Electronic Health Record Incentive Program which was designed to help move people over to electronic records and improve the systems that were already in place.
They took part in the Medicare Physician Quality Reporting System (PQRS).